- Home
- NCNA vs ADIL Comparison
NCNA vs ADIL Comparison
Compare NCNA & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCNA | ADIL |
|---|---|---|
| Founded | 1997 | 2010 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5M | 18.5M |
| IPO Year | 2017 | 2017 |
Fundamental Metrics
Financial Performance| Metric | NCNA | ADIL |
|---|---|---|
| Price | $1.30 | $4.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $37.50 |
| AVG Volume (30 Days) | ★ 59.9K | 47.5K |
| Earning Date | 06-01-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.21 | $0.13 |
| 52 Week High | $7.01 | $7.20 |
Technical Indicators
Market Signals| Indicator | NCNA | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 43.07 | 42.01 |
| Support Level | $1.21 | $2.38 |
| Resistance Level | $1.41 | $5.08 |
| Average True Range (ATR) | 0.06 | 0.55 |
| MACD | -0.00 | -0.22 |
| Stochastic Oscillator | 50.00 | 17.49 |
Price Performance
Historical ComparisonAbout NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.